Research graph
References from Veillonella dispar triggers “dual-hits” in the pathogenesis of autoimmune hepatitis and primary biliary cholangitis via testosterone depletion-BAFF-B cell axis and Th17 cell activation. Local targets link to admitted publications; unresolved targets remain external evidence.
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis
10.1016/j.eclinm.2023.102280 · 2023 · External reference
10.1111/jgh.15329
10.1111/jgh.15329 · External reference
10.1136/bmj-2022-070201
10.1136/bmj-2022-070201 · External reference
Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-Analysis
10.1016/j.cgh.2025.03.025 · 2026 · External reference
10.1136/gutjnl-2024-333171
10.1136/gutjnl-2024-333171 · External reference
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
10.1016/j.jhep.2025.03.017 · 2025 · External reference
10.1002/hep.30145
10.1002/hep.30145 · External reference
10.1136/gutjnl-2017-315259
10.1136/gutjnl-2017-315259 · External reference
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
2023 · External reference
The Possible Effects of Ursodeoxycholic Acid on Recurrent Primary Biliary Cholangitis and Biliary Complications After Liver Transplant
2021 · External reference
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis
10.1016/j.jhep.2020.03.043 · 2020 · External reference
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
10.1038/s41575-019-0226-7 · 2020 · External reference
10.1016/s0140-6736(24)01303-5
10.1016/s0140-6736(24)01303-5 · External reference
Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
10.1007/s12072-025-10965-6 · 2026 · External reference
10.1038/cmi.2018.7
10.1038/cmi.2018.7 · External reference
Role of microbiome in autoimmune liver diseases
10.1097/hep.0000000000000506 · 2024 · External reference
10.1136/gutjnl-2016-313332
10.1136/gutjnl-2016-313332 · External reference
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
10.1016/j.medj.2024.08.003 · 2025 · External reference
10.1136/gutjnl-2018-317836
10.1136/gutjnl-2018-317836 · External reference
Epidemiology and surveillance of autoimmune hepatitis in Asia
10.1111/liv.15155 · 2022 · External reference
Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases
10.1016/j.autrev.2015.03.008 · 2015 · External reference
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome
2021 · External reference
10.1016/j.jhep.2010.09.002
10.1016/j.jhep.2010.09.002 · External reference
10.1002/hep.1840110106
10.1002/hep.1840110106 · External reference
10.1053/jhep.2000.8090
10.1053/jhep.2000.8090 · External reference
10.1038/s41467-018-04408-0
10.1038/s41467-018-04408-0 · External reference
10.3390/microorganisms8071011
10.3390/microorganisms8071011 · External reference
10.1172/jci108729
10.1172/jci108729 · External reference
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response
10.4049/jimmunol.159.1.3 · 1997 · External reference
10.4049/jimmunol.1400076
10.4049/jimmunol.1400076 · External reference
10.1001/archneur.64.5.683
10.1001/archneur.64.5.683 · External reference
10.1093/rheumatology/35.6.568
10.1093/rheumatology/35.6.568 · External reference
10.1210/jc.2009-0106
10.1210/jc.2009-0106 · External reference
Immunological abnormalities in patients with primary biliary cholangitis
10.1042/cs20181123 · 2019 · External reference
IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis
10.1016/j.jhepr.2023.100757 · 2023 · External reference
Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis
10.1111/liv.12245 · 2014 · External reference
10.1002/hep.27313
10.1002/hep.27313 · External reference
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
10.1016/j.jhepr.2019.10.005 · 2019 · External reference
10.1111/j.1365-2249.2009.03947.x
10.1111/j.1365-2249.2009.03947.x · External reference
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy
10.1016/j.jaut.2024.103327 · 2024 · External reference
